CLS B — Clinical Laserthermia Systems AB Share News
0.000.00%
Last trade - 00:00- SEK109.86m
- SEK93.54m
- SEK17.49m
Sweden's CLS Q1 sales fall 72% after partner talks
Brief: Clinical Laserthermia Systems Q1 EBIT Sek 1.7 Mln
Brief: CLS Receives Order Worth SEK 23 Mln For Prism Business
Brief: CLS Expects To Achieve Positive Cash Flow From Q4 2026 To Q1 2028
Brief: Clinical Laserthermia Systems Says Continues To Maintain Targets For 2026
Brief: CLS Initiates Recruitment Process For Permanent Chief Financial Officer
Brief: Clinical Laserthermia Systems Q3 Revenue SEK 2.8 Mln
Brief: CLS Raises SEK 20.9 Mln Through Full Subscription Of Warrants
Brief: Clinical Laserthermia Systems Gets FDA Clearance For Expanded Labeling
Brief: CLS H1 Oper Loss At SEK 10.8 Mln
Brief: Clinical Laserthermia Systems Q1 Basic EPS SEK -0.68
Brief: Clinical Laserthermia Systems To Carry Out A Directed Issue Of 5.5 Mln Units
Brief: Clinical Laserthermia Systems Q4 Net Sales SEK 4.6 Mln
Brief: CLS Carries Out Compensation Issue In Connection With Completed Exercise Of Warrants
Brief: CLS Gets SEK 22.4 Mln Through Exercise Of Warrants, Decides On Directed Issue
Brief: CLS Gets Additional Guarantee Commitments Of About SEK 5.8 Mln For Warrants Of Series TO 7 B
Brief: Clinical Laserthermia Systems Q3 Loss After Financial Items Narrows To SEK 13.0 Mln
Brief: Cls Enters Subscription Undertakings
Brief: CLS To Streamline Ops, Focus On Neurosurgery Biz